Impact of eIF3a 2554G>A genetic polymorphism on clinical sensitivity to platin-based chemotherapy in patients with lung cancer

Han Lifang,Xu Xiaojing,Shen Jie,Pei Qi,Fu Jian,Zhou Honghao,Liu Zhaoqian

DOI: https://doi.org/10.3969/j.issn.2095-1264.2011.01.010

2011-01-01

Abstract:Objective eIF3a plays an essential role in the regulation of initiation of mRNA transcription and protein translation in mammalian cells.Recent studies showed that eIF3a protein is over-expressed in lung cancer tissues.The aims of this study were to explore whether eIF3a 2554G>A genetic polymorphism is associated with the susceptibility of lung cancer development and clinical responses to platinum-based chemotherapy in patients with lung cancer.Method Blood samples in all subjects were collected from the Xiangya hospital of Central South University,Changsha,Hunan Province,P.R.China. The genotyping analysis of eIF3a 2554G>A were determined by hemi-nested polymerase chain reaction restriction fragment length polymophism(PCR-RFLP).Results The allele frequencies of eIF3a 2554G>A in healthy control,lung cancer,small cell lung cancer,squamous cell carcinoma,and adenocarcinoma were 15.3%,10.9%,15.7%,13.4%,and 6.6%,respectively.The frequencies of eIF3a 2554 GG,GA and AA in patients with lung cancer were 78.8%,20.6%and 0.6%respectively.The frequencies of eIF3a 2554 GG,GA and AA in healthy control were 72.9%,23.5%and 3.5%respectively.There was no significant statistical difference in risk for lung cancer between the groups of GA,AA,GA+AA and the group of GG.After a balance in age,sex,and smoking status of all subjects,compared with group of GG genotype,the OR of the group of GA genotype,AA genotype and GA+AA genotype are 0.83(95% CI:0.49～1.41),0.18(95%CI:0.02～1.59) and 0.76(95%CI:0.45～1.27) respectively.In patients with small cell lung cancer,GA genotypic individuals had better platinum-based chemotherapy responsive tendency compared with GG genotype.The non-small cell lung cancer patients with GG genotype also had better chemotherapy responsive tendency compared with GA+AA genotype.Conclusion The data suggests that the genetic polymorphism of eIF3a 2554G>A may be associated with platinum-based chemotherapy sensitivity in Chinese patients with lung cancer.